Capsular Polysaccharide Biology in Staphylococcus aureus

Staphylococcus aureus produces a surface‐associated capsular polysaccharide (CP) that forms a protective layer around the cell, mediating immune evasion and enhancing survival in hostile host environments. Two predominant serotypes, CP5 and CP8, differ in carbohydrate composition yet share a conserved biosynthetic pathway encoded by the cap operon. Biosynthesis begins with UDP‐N‐acetyl‐d‐glucosamine modifications catalysed by a suite of enzymes, followed by polymer assembly and export through dedicated transporters. Expression of the cap operon is intricately regulated at both transcriptional and post‐transcriptional levels, balancing energy expenditure with virulence needs. The capsule masks underlying surface proteins, inhibits complement deposition, and reduces phagocytosis, making it a critical virulence determinant and a prime vaccine antigen candidate. Recent advances in structural biology, regulatory networks and molecular epidemiology have deepened understanding of capsule heterogeneity, modulation during infection and avenues for therapeutic intervention.

Research from Nature Portfolio

Recent studies have identified small‐molecule inhibitors that target CapF, a bifunctional metalloenzyme essential for the early steps of CP precursor synthesis. Fragment‐based screening revealed tropolone derivatives that bind the zinc‐dependent active site, disrupt substrate coordination and destabilise the enzyme’s cupin domain, providing a structural framework for the rational design of capsule biosynthesis inhibitors. Another investigation into within‐host evolution of S. aureus during bovine mastitis uncovered the emergence of sigma factor B‐deficient variants. These variants display a shift towards poly‐N‐acetylglucosamine‐based biofilm production, heightened proteolytic activity and attenuated acute virulence, underscoring the plasticity of global regulators in reshaping polysaccharide profiles and persistence strategies in vivo.

Capsular Polysaccharide Biology in Staphylococcus aureus publication trend

The graph below shows the total number of articles in capsular polysaccharide biology in staphylococcus aureus across all publications each year (not limited to Nature Index journals).

Technical terms

Capsular polysaccharide (CP): A high‐molecular-weight carbohydrate layer surrounding bacterial cells that shields against immune defences and contributes to virulence.

CapF: A zinc-dependent bifunctional enzyme that catalyses the dehydration and epimerisation steps in the early stages of CP precursor biosynthesis.

Sigma factor B (SigB): A stress‐responsive transcription factor that activates alternative promoters, including those controlling capsule gene expression in S. aureus.

Poly-N-acetylglucosamine (PNAG): A biofilm polysaccharide produced by S. aureus that mediates intercellular adhesion and contributes to persistent infections.

References

1. Bacterial capsules: Occurrence, mechanism, and function. npj Biofilms and Microbiomes (2024).
2. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States. PLOS ONE (2019).
3. Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus. Scientific Reports (2015).
4. Revisiting the regulation of the capsular polysaccharide biosynthesis gene cluster in Staphylococcus aureus. Molecular Microbiology (2019).
5. Within-host evolution of bovine Staphylococcus aureus selects for a SigB-deficient pathotype characterized by reduced virulence but enhanced proteolytic activity and biofilm formation. Scientific Reports (2019).